These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neonatal BCG policy and childhood tuberculosis in the Republic of Ireland. Johnson H. Commun Dis Rep CDR Rev; 1993 Aug 13; 3(9):R132-4. PubMed ID: 7693174 [Abstract] [Full Text] [Related]
3. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland. Sweeney E, Dahly D, Seddiq N, Corcoran G, Horgan M, Sadlier C. BMC Infect Dis; 2019 May 09; 19(1):397. PubMed ID: 31072396 [Abstract] [Full Text] [Related]
5. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries. Brantsaeter AB, Romanus V, Andersen PH, Heldal E. Int J Tuberc Lung Dis; 2009 Apr 09; 13(4):440-5. PubMed ID: 19335948 [Abstract] [Full Text] [Related]
6. Selective BCG vaccination in a country with low incidence of tuberculosis. Romanus V. Euro Surveill; 2006 Apr 09; 11(3):14-7. PubMed ID: 16567880 [Abstract] [Full Text] [Related]
7. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Menzies D. Clin Infect Dis; 2000 Sep 09; 31 Suppl 3():S71-4. PubMed ID: 11010826 [Abstract] [Full Text] [Related]
9. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Lanckriet C, Lévy-Bruhl D, Bingono E, Siopathis RM, Guérin N. Int J Epidemiol; 1995 Oct 09; 24(5):1042-9. PubMed ID: 8557438 [Abstract] [Full Text] [Related]
10. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program]. Ushio M. Kekkaku; 2005 Jul 09; 80(7):541-6. PubMed ID: 16167781 [Abstract] [Full Text] [Related]
11. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N. Vaccine; 2007 Jan 02; 25(1):14-8. PubMed ID: 16959383 [Abstract] [Full Text] [Related]
12. Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021. Jackson S, Kabir Z, Comiskey C. Vaccine; 2024 Mar 19; 42(8):2099-2105. PubMed ID: 38423810 [Abstract] [Full Text] [Related]
13. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines. Dierig A, Tebruegge M, Krivec U, Heininger U, Ritz N, Paediatric Tuberculosis Network European Trials group (ptbnet). Vaccine; 2015 Sep 11; 33(38):4994-9. PubMed ID: 26151543 [Abstract] [Full Text] [Related]
18. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada. Cook VJ, Hernández-Garduño E, Kunimoto D, Hershfield ES, Fanning EA, Hoeppner VH, Elwood RK, FitzGerald JM, Canadian Molecular Epidemiology of Tuberculosis Study Group. Can Respir J; 2005 Apr 11; 12(3):134-8. PubMed ID: 15875064 [Abstract] [Full Text] [Related]
19. Evaluation of bacille Calmette-Guérin immunisation programs in Australia. Khandaker G, Beard FH, Dey A, Coulter C, Hendry AJ, Macartney KK. Commun Dis Intell Q Rep; 2017 Mar 31; 41(1):E33-E48. PubMed ID: 28385137 [Abstract] [Full Text] [Related]
20. Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children. Chan PC, Chang LY, Wu YC, Lu CY, Kuo HS, Lee CY, Huang LM, Chen CJ. Int J Tuberc Lung Dis; 2008 Dec 31; 12(12):1401-6. PubMed ID: 19017449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]